RELATED PARTY TRANSACTIONS (Details) - USD ($)	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
Due to (from) related parties at beginning of period	$ 920,782	$ (101,297)
Amounts invoiced by Pharma to DDL, NM and TCL primarily relating to research and development expenses	4,211,705	2,833,546
Amounts invoiced by DDL to Pharma	0	(3,159)
Amounts received from Pharma	0	4,452
Amounts paid by DDL to Pharma	(4,311,770)	(2,789,939)
Foreign exchange differences	(20,314)	31,077
Due to (from) related parties at end of period	$ 800,403	$ (25,320)